drugset / Trial / NCT05466578
Pre-approval Single-patient Expanded Access for Abrocitinib (PF-04965842)
Summary
Provide pre-approval single patient Expanded Access (compassionate use) of abrocitinib for patients with severe uncontrolled atopic dermatitis
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Abrocitinib | Small molecule | — | — |